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Production of extracellular matrix by glomerular epithelial cells
is regulated by transforming growth factor-f31
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Production of extracellular matrix by glomerular epithelial cells is
regulated by transforming growth factor-J31. Transforming growth fac-
tor-/3 (TGF-f3) has widespread effects on extracellular matrix produc-
tion by many cultured cell lines and appears to play a role in the
pathological accumulation of extracellular matrix that accompanies
inflammatory and fibrotic diseases such as glomerulonephritis. Earlier
experiments have shown that mesangial cells respond to TGF-/31 with a
marked increase in the production of two chondroitin/dermatan sulfate
proteoglycans, decorin and biglycan, but their production of other
matrix components elevated in glomerulonephritis is not substantially
affected by TGF-I. Since the glomerular epithelial cells are also
thought to contribute to matrix production in the glomerulus, we
examined the ability of these cells to produce some of the nonproteo-
glycan matrix components in response to TGF-j31. Exposure of glomer-
ular epithelial cells to TGF-pl increased the production of fibronectin
and type IV collagen, in addition to biglycan. Enhancement of the cell
layer accumulation of laminin was also observed. These results show
that TGF-/31 has a differential effect on extracellular matrix production
by epithelial and mesangial cells from glomeruli. TGF-/31 released in the
glomerulus secondary to injury could thus affect both cell types and
lead to increased intraglomerular production of proteoglycans, whereas
the increased fibronectin, type IV collagen, and laminin may primarily
originate from the epithelial cells.
Glomerular extracellular matrix is a complex superstructure
of interacting macromolecules that surrounds the mesangial
cells and, in a specialized form as the glomerular basement
membrane, separates the capillary endothelium from the vis-
ceral epithelium [I]. The glomerular extracellular matrices
contribute importantly to the structural organization of the
glomerulus and to the biophysical properties that govern gb-
merular filtration and permeability [21. Moreover, progressive
glomerular disease is usually associated with marked thickening
and/or expansion of the matrices [3—6].
In the primitive gbomerulus endothelial cells contribute to the
formation of the early glomerular basement membrane, how-
ever, with development endothelial synthesis of matrix mole-
cules seems to stop [I]. Thus in the mature glomerulus it is
likely that mesangial and epithelial cells are primarily respon-
sible for biosynthesis and maintenance, respectively, of the
mesangial matrix and the gbomerular basement membrane.
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These two types of gbomerular matrices are each composed
principally of heparan sulfate proteoglycans, chondroitin/der-
matan sulfate proteoglycans, fibronectin, laminin, and type IV
collagen [1, 7, 8]. The biosynthesis of several of these key
matrix components has recently been shown to be regulated by
transforming growth factor-/3 (TGF-/3) [9, 10].
TGF-/3 is a prominent member of a family of cell regulatory
proteins and is unique among growth factors in its broad effects
on extracellular matrix [9—111. Three isoforms of TGF-/3 (1, 2
and 3) have been identified in mammals [II]. TGF-/31 stimulates
synthesis of collagen, fibronectin and proteoglycans in a num-
ber of cultured cell lines [9, 10] and when injected in vivo it
causes accumulation of extracellular matrix [12]. There is
strong evidence for the involvement of TGF-J31 in the accumu-
lation of extracellular matrix in kidney disease. In a rat model of
experimental glomerulonephritis induced by specific immuno-
logical injury to the mesangial cell, there is a striking increase in
proteoglycan and fibronectin production by isolated nephritic
glomeruli in culture [13]. Moreover, conditioned medium from
the nephritic glomerular cultures contained increased amounts
of active TGF-/3l, and there was an increased expression of
TGF-/31 mRNA and TGF-f31 protein in the glomeruli. Addition
of anti-TGF-/31 to the glomerular cultures markedly suppressed
the synthesis of proteoglycans and fibronectin. In a related
study, administration of anti-TGF-/31 to glomerulonephritic
rats, markedly suppressed the histological manifestation of
extracellular matrix accumulation [14].
In a study on isolated rat mesangial cells we found that
TGF-/3l strongly induced the production of two chondroitin/
dermatan sulfate proteoglycans, biglycan and decorin, by the
cultured mesangial cells [15]. The synthesis of the other matrix
components elevated in the glomerulonephritis model was not
increased in the TGF-f31-treated mesangial cells. Since TGF-131
production in the gbomerulus is also likely to affect the epithelial
cells, we designed the current study to characterize the action
of TGF-/31 on extracellular matrix production by rat glomerular
epithelial cells in culture. We found that TGF-/31, in addition to
enhancing the synthesis of proteoglycans, increased the pro-
duction of fibronectin and type IV collagen by the epithelial
cells. This difference in the biosynthetic profile of matrix
production by mesangial and epithelial cells suggests that the
epithelial cells may be the cell type that contributes the non-
proteoglycan component to the TGF-pl induced expanded
matrix in experimental glomerulonephritis.
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Fig. I. Morphological and
i,nmunofluorescence identification of cultured
glomerular visceral epithelial cells. Typical
cobblestone appearance of cells grown on a
laminin coated plate (A). Cells were uniformly
stained with an antibody to vimentin (B) but
did not stain with an antibody to cytokeratin
(C), indicating that they are of visceral
epithelial cell origin. Magnification x500.
Methods
Growth factors and antibodies
Porcine TGF-/31 was obtained from R&D Systems, Inc.
(Minneapolis, Minnesota, USA). Human platelet-derived
growth factor (PDGF), and recombinant human interleukin-1
(IL-I), alpha and beta, were from Collaborative Research, Inc.
(Bedford, Massachusetts, USA), recombinant human tumor
necrosis factor (TNF) was from Amgen (Thousand Oaks,
California, USA). Goat anti-human types I, III and IV collagen
antibodies were purchased from Southern Biotechnology Asso-
ciates, Inc. (Birmingham, Alabama, USA). The antibody to
type IV collagen reacts with the a1 and a2 subunits present in
the helical domains of the type IV collagen molecule contained
in the glomerular basement membrane. Rabbit antibodies to
mouse fibronectin, were affinity purified on fibronectin and
laminin, respectively, and isolated by chromatography as de-
scribed [16, 17]. Rabbit antibody to mouse type VI collagen was
absorbed with normal mouse serum coupled to Sepharose and
used as absorbed serum [18]. Each of these reagents specifically
immunoprecipitated the appropriate antigen from medium con-
ditioned by metabolically labeled cells l6—l8 and results in this
paper]. Rabbit antiserum produced against a synthetic peptide
from the core protein of human biglycan was a generous gift
from Dr. L. W. Fisher, National Institutes of Health. Mono-
clonal antibody to rat Thy-I was obtained from Accurate
Chemicals (Westbury, New York, USA) and goat anti-human
factor VIII from Miles Laboratory Inc. (Kankokee, Illinois,
USA). Rabbit anti-rat FXIA antibody was produced by immu-
nization with FXIA prepared from the kidney of Sprague-
Dawley rats as described [19]. FITC and alkaline phosphatase
labeled anti-rabbit IgG or anti-goat IgG were obtained from
Cappel (Melvern, Pennsylvania, USA).
Cell culture
Glomerular epithelial cells were obtained from outgrowth of
intact glomeruli obtained from six to eight-week-old Sprague-
Dawley rats. To isolate epithelial cells, intact glomeruli were
placed in flasks coated with type I collagen (Vitrogen, Collagen
Corp., Palo Alto, California, USA). The growth medium was
RPM! 1640 (CelI-Gro, Washington, D.C., USA) supplemented
with 20% heat-inactivated fetal calf serum (FCS; Hyclone,
Logan, Utah, USA), 50 U/mI penicillin, 100 tg/ml streptomy-
cm, 0.66 U/mI insulin and 300 mg/mI L-glutamine. After seven
days, outgrowing cells were detached with 0.025% trypsin-
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Fig. 2. Effects of growth factors on synthesis of proteins by glomerular
epithelial cells. Cultured glomerular epithelial cells were treated with
growth factors for 48 hours and metabolically labelled with 35S methi-
onine. Equal volumes of conditioned media were analyzed by SDS-
PAGE and fluorography. TGF-/31 treatment increased the density of
several bands derived from proteins secreted into the medium.
0.5 M EDTA (Flow Labs, McLean, Virginia, USA). Glomerular
debris was removed by passing the material through a 30-mesh
screen. A highly enriched epithelial cell population was pro-
duced by using an indirect panning technique modified from the
method of Wyoocki and Sato [20]. In this procedure mesangial
cells were preferentially eliminated by binding to plates coated
with anti-Thy-I antibody; mesangial cells but not epithelial
possess a Thy-i-like epitope on their surface [21]. Glomerular
cells were added to 60 x 15 mm polystyrene plates, which were
precoated with mouse anti-Thy-I antibody by 12 hours incuba-
tion at 4°C. Nonadherent cells were removed and placed in
6-well plates precoated with laminin by incubating I ml of
laminin (Collaborative Research) dissolved in phosphate buff-
ered saline (PBS) at 10 jzg/ml overnight at 4°C. The solution was
removed, the plates washed x3 with PBS and used as laminin
coated plates. In separate experiments, we found no differences
in cell morphology or response to TGF-/3 when using laminin or
Fig. 3. Effect of TGF-/31 on fibronectin production by glomerular
epithelial cells. Equal volumes of media and extracts of cell layers from
control cells or cells treated with 25 ng/ml of TGF-131 were immuno-
precipitated with antisera to fibronectin. Preimmune serum was used as
control (C). TGF-f31 increased fibronectin secretion into the medium
and deposition into the cell layer.
type I collagen plates. Laminin was arbitrarily chosen for use in
the remainder of the study.
Glomerular epithelial cells were identified by: (I) character-
istic polygonal morphology (Fig, IA), (2) uniform staining with
antibody to FX1A (Heymann antigen) [22], (3) sensitivity to
aminonucleoside of puromycin, and (4) no staining with anti-
Thy-I or anti-Factor VIII antibody. Contamination of glomer-
ular epithelial cells by proximal tubular cells was examined by
alkaline phosphatase staining; less than 2% of the cells were
alkaline phosphatase positive. To distinguish glomeruiar vis-
ceral from parietal epithelial cells, coverslip preparations were
stained with antibodies to cytokeratin (Labsystems, Helsinki,
Finland) and vimentin (BioGenex Laboratories, San Ramon,
California, USA). Giomerular visceral epithelial cells are posi-
tive for vimentin and negative for cytokeratin, whereas parietal
epithelial cells are negative for vimentin and positive for cyto-
keratin [23, 24j. Using this approach our cells were shown to be
visceral epithelial cells (Fig. 1 B and C).
Biosynthetic radiolabeling
Glomerular epithelial cells were added to laminin-coated
6-well multiwell plates at a concentration of 5 x l0 cells per
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welland cultured in serum-free RPM! 1640 medium for 24 hours
to arrest cell proliferation. Non-adherent cells were removed by
washing with PBS. Serum and antibiotic-free RPM! 1640 was
added as a low sulfate medium for 35S-sulfate labeling and
RPM! 1640 without methionine (Flow Labs) for SSmethionine
labeling. Dose response experiments were conducted using
TGF-/3 at concentrations of 0.5, 2.5, 7,5, 25, and 50 ng/mI and
PDGF at 5, 10, 30, and 100 ng/ml. The concentrations chosen
for the study were: TGF-pl (25 ng/ml), PDGF (5 ng/ml), IL-la
(5 U/mI), IL-1/3 (5 U/mI) and TNF (500 U/mi). Growth factors
were added to the media for 48 hours as in our previous study
[151. Eighteen hours prior to termination of the experiment,
35S-methionine (100 Ci/ml), to label proteins or 5S-sulfate
(200 /LCi/ml) to label proteoglycans, were added to the cultures,
Identification of extra cellular matrix molecules
Matrix glycoproteins were identified by immunoprecipitation
and proteoglycans by enzyme digestion. Irnmunoprecipitations
were performed by adding 100 d of antiserum to 500 l of
conditioned medium or 300 rl of cell extract collected from
duplicate wells in the presence or absence of added growth
factors. In additional duplicate wells, cells were detached and
counted to ensure uniformity of cell number. Preimmune serum
was used in parallel control experiments. The samples were
incubated overnight at 4°C with mixing in 4 ml conical tubes
precoated with bovine serum albumin (BSA). Protein-A-Seph-
arose beads (Sigma) were preincubated with fresh RPM! for 60
minutes at 22°C. To precipitate the antigen-antibody com-
plexes, 50 jl of suspended protein-A-Sepharose was added to
the samples, and mixed at 4°C for 120 minutes. The samples
were centrifuged for 10 minutes at 2000 )< g and the supernatant
removed, The pellets were washed 10 times with I ml of ice cold
PBS containing 0.5 M NaCI, 0.1% SDS and 1% Triton X-100 pH
7.4. Finally, the pellets were washed with ice cold PBS,
transferred to new tubes, recentrifuged, and washed three times
with PBS. The pellets were dissolved in 40 d of SDS-PAGE
sample buffer containing 3% SDS and 10% f3-mercapto-ethanol
(Sigma) and boiled for five minutes. To guarantee that immu-
noprecipitation resulted in complete recovery of the matrix
components from the conditioned medium, varying concentra-
tions of antiserum and conditioned medium were utilized. The
samples were analyzed by SDS-PAGE and densitometry. These
experiments showed a linear relationship between densitomet-
nc values of the gel and the amount of antisera or medium
utilized. Also gels run from the supernatants from the immuno-
precipitated medium showed total absence of the respective
matrix component indicating complete removal of the compo-
nent by the antiserum.
Enzymatic digestion to identify proteoglycans was performed
on conditioned media after biosynthetic labeling. Aliquots of
medium (25 1d) were mixed with 100 milliunits of chondroiti-
nase ABC or chondrojtinase AC both in 100 m'vi Tris-HCI, pH
7.5, 10 m calcium acetate, 2 mg/mI BSA or 100 milliunits of
heparinase II in 50 mtt Tris-HCI, pH 7.4, 1 mM calcium
chloride, 5 mii calcium acetate. All samples also received 1 mM
PMSF, 5 mrvt benzamidine, 100 g/ml soy bean trypsin inhibi-
tor, 10 pg/mI leupeptin and 10 pg/mI antipain. All materials
were obtained from Sigma. Chondroitinase-containing mixtures
were incubated at 37°C for 1.5hours, and heparinase containing
Fig. 4. Effect of TGF-/31 on type IV collagen production by glomerular
epithelial cells. Equal volumes of media and extracts of cell layers from
control cells or cells treated with 25 ng/ml TGF-/31 were immunopre-
cipitated with antisera to type IV collagen. Preimmune serum was used
as control (C). TGF-/31 increased type IV collagen secretion into the
medium and deposition into the cell layer.
mixture at 22°C for 1.5 hours. At termination samples were
prepared for SDS-PAGE.
Proteoglycans were also characterized by gel filtration. 355
sulfate labeled fractions from a Sepharose CL-6B column were
dialyzed against distilled water and lyophilized. Samples were
dissolved in 2 ml of 0.1 M sodium acetate 0.1 M Tris, pH 7.3,
containing protease inhibitors as previously described [15].
Then 0,2 ml of chondroitinase ABC solution (1.25 U/mI) was
added to 1.8 ml of sample and digestion carried out for 24 hours
at 37°C. Samples were then fractionated on a Sepharose CL-6B
column, dialyzed against distilled water, lyophilized and treated
with nitrous acid under low pH (1.0) conditions. After treatment
with nitrous acid, samples were rechromatographed on the
Sepharose column.
To quantitate the production of proteoglycans by cultured
cells, three ml of conditioned medium were fractionated on a
Sepharose CL-6B column. The column was eluted with 4 M
urea, 0.15 M NaCI, 50 mi Tris HCI, pH 7.2, 0.1% (vol/vol)
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Fig. 5. Effect of TGF-131 on collagen
production by glomerular epithelial cells.
Equal volumes of media and extracts of cell
layers from cells treated with 25 ng/ml of
TGF-f31 were immunoprecipitated with
antisera to types I, Ill, IV and VI collagen.
Preimmune serum was used as control (C).
TGF-/31 failed to induce the production of
types I, III or Vt collagens.
Triton X-l00. The radioactivity in each effluent fraction was
determined by a Beckman LS 2800 liquid scintillation counter.
Electrophoretic technique
All samples for SDS-PAGE were mixed with sample buffer
containing 3% SDS, I mrvi PMSF and 10% /3 mercaptoethanol
and heated for five minutes at 100°C. Aliquots (20 ,.d) were
equally applied to 4 to 12% gradient gels (Novex, Encinitas,
California, USA) and run for three hours at constant power.
Gels were all run reduced and were stained with Coomassie
Blue. Molecular size markers were from Pharmacia (Uppsala,
Sweden). Fluorography was performed by incubating gels in
Enlightning (New England Nuclear, Boston, Massachusetts,
USA). Typical exposure times for 35S methionine were one to
two days and for S sulfate three to five days. Fluorograms
were scanned with an ultrascan XL Enhanced Laser Densitom-
eter (Pharmacia) to compare and quantitate the relative inten-
sities and mobilities of the protein and proteoglycan bands.
Fluorograms exposed for different time periods were scanned
and the densitometric values were found to have a linear
relationship to exposure time.
Results
Effects of TGF-f31 on production of extracellular matrix
proteins
Biosynthetic labeling of cultured glomerular epithelial cells
with 35S-methionine was employed to label newly synthesized
matrix proteins. Figure 2 shows that exposure to TGF-/31
increased the density of several protein bands identified by
SDS-PAGE. In contrast, the other growth factors tested had no
significant effect on the protein synthesis pattern. In a separate
experiment higher doses of PDGF (10, 30 and 100 ng/ml) were
tested and showed no effect on stimulating protein synthesis
(data not shown). Immunoprecipitation of the conditioned
media and the extracted cell layers showed that the major
effects of TGF-/3l were to increase the quantity of fibronectin
(Fig. 3) and type IV collagen (Fig. 4) secreted into the medium
and incorporated into the matrix of the cell layer. In five
independent experiments the increase in fibronectin secretion
averaged 306% and varied between 250 and 370%; type IV
collagen secretion averaged 329% and varied between 237 and
412%. There was no visible effect on type I, III or VI collagen
(Fig. 5). TGF-/3l did not alter secretion of laminin, or a 150 kD
band presumed to be entactin/nidogen. However, deposition of
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Epithelial cell Table 1. Laser densitometric analysis of proteins immunoprecipitated
from media and extracted cell layers of glomerular epithelial cells
Layer
7 Matrix proteins
Sample TGF-/3l Fibronectin Type LV collagen Laminin
Medium —
+
0.3°
0.9
0.2°
0.5
0.1°
0.1
Cell layer —
+
0.3
1.3
0.3
0.7
0.1
0.3
The cells were labeled with 35S-methionine and immunoprecipitated
with specific antibodies.
A U Values are major bands at or above 200 kD shown in Figs. 3, 4 and
6 but exclude bands at the top of each lane.
Fig. 6. Effect of TGF-f31 on laminin production by glomerular epithe-
ha! cells. Equal volumes of media and extracts of cell layers from
control cells or cells treated with 25 ng/ml of TGF-/31 were immuno-
precipitated with antisera to mouse laminin. Preimmune serum was
used as control (C). TGF-/3l slightly increased laminin deposition into
the cell layer. The A, BI and B2 chains of laminin were tentatively
identified and are indicated by arrows and the respective letters. The
bands at 300 kD and 90 kD likely represent the two proteolytic
fragments of the M chain of merosin. The M chain is related to the
laminin A chain and shares the B chains with laminin and, therefore, is
precipitated by the anti-laminin reagent used here 1281. The band at ISO
kD is thought to represent entactin/nidogen, which binds to laminin and
coprecipitates with it. The unidentified bands at 40 kD seen in all lanes
are nonspecific.
laminin into the cell layer was slightly increased in the TGF-
/31-treated cells (Fig. 6). Each of the gels shown in Figures 3, 4
and 6 was scanned by laser densitometry and the quantitative
results are shown in Table 1.
Effect of TGF-f31 on production of proteoglycans
We have previously shown that TGF-/31 induces the produc-
tion of two chondroitin/dermatan sulfate proteoglycans, bigly-
can and decorin, by rat mesangial cells [15]. For epithelial cells
Fig, 7. Effect of growth factors on proteoglycan production by glower-
ularepithelialcells. Cultures of glomerular epithelial cells were treated
with growth factors for 48 hours and metabolically labeled with °5S-
sulfate. Equal volumes of conditioned media were analyzed by SDS-
PAGE and fluorography. TGF-/31 increased the band centered at 220 to
300 kD in conditioned media from glomerular epithelial cells. PDGF,
TNF, IL-la and lL-lj3 had no effect on proteoglycans.
exposed to TGF-/3l, there was a substantial increase of a
35S-sulfate-labeled proteoglycan band, centered at 220 to 300
kD (Fig. 7). The increase in proteoglycan production averaged
482% and varied between 352 and 655% in five independent
experiments. The other growth factors tested did not change
proteoglycan production (Fig. 7), as had been observed with
cultured inesangial cells [15]. Addition of increasing concentra-
tions of TGF-/3l produced a dose response effect (Fig. 8). The
maximal effect was seen at 25 ng/ml of TGF-f3l, which caused
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Fig. 8. Dose response effects of TGF-f3I on proteoglycan production
by glomerular epithelia! cells. Cultures of glomerular epithelial cells
were treated with TGF-/31 for 48 hours and proteoglycans were ana-
lyzed as described in the legend of Figure 7. At 25 ng/ml a shift in the
electrophoretic mobility and a 5-fold increase in the amount of the 220
to 300 kD proteoglycan are seen.
Fig. 9. Characterization of the proteoglycans produced by gtomerular
epithelial cells. Metabolically labeled medium from glomerular epithe-
hal cell cultures treated with TGF-/3l (25 ng/ml) was subjected to
specific enzyme digestion. The samples were treated with: (lane I)
saline, (2) heparinase, (3) heparitinase, (4) chondroitinase ABC, (5)
chondroitinase AC. The band was digested in the sample in lane 4
indicating the presence of chondroitin/dermatan sulfate proteoglycan.
A B
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Fraction number
Fig. 10. Gel filtration analysis of the proteoglycans affected by TGF-pi. Symbols are: (—0-——-) TGF-/3(—); (———--) TGF-/3(+).
Metabolically labeled medium from control glomerular epithelial cells or TGF-/31 (25 ng/ml) treated cell cultures were applied onto a Sepharose
CL-6B column before (A) and after (B) digestion with chondroitinase ABC. TGF-J3l induced a twofold increase in the production of total
proteoglycans. The change was caused by an increase in the chondroitinase ABC sensitive fraction.
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Fig. 11. Effect of TGF-/31 on proliferation of glomerular epithelial
cells. TGF-/3 suppressed the 3H-thymidine uptake by glomerular epi-
thelial cells. Values are mean sn of six wells. P < 0.001 TGF-/3
compared to control analyzed by t-test.
a fivefold increase in proteoglycan production. In a separate
dose response experiment, PDGF (10, 30 and 100 nglml) did not
significantly affect proteoglycan synthesis (data not shown).
Extraction of the cell layer showed only a slight increase in
proteoglycan incorporation following exposure to TGF-f31 (data
not shown), indicating that the majority of the proteoglycan
induced by TGF-flI is released into the medium.
Digestion with enzymes was used to determine the type of
proteoglycans induced by TGF-J31 in the epithelial cell cultures.
The proteoglycan at 220 to 300 kD was found to be degraded by
chondroitinase ABC, but not by heparinase, heparitinase or
chondroitinase AC (Fig. 9); this indicates that it is a chon-
droitin/dermatan sulfate proteoglycan. The proteoglycan was
further characterized as being biglycan by immunoprecipitation
using antiserum to a synthetic peptide of the core protein of
human biglycan (data not shown). A proteoglycan band, too
large to enter the gel, is seen at the top of each lane in Figure 9.
In order to include this band in our analysis, we evaluated the
35S-sulfate labeled proteoglycans by a combination of digestion
with specific enzymes and gel filtration chromatography. In
control experiments we found that epithelial cells secrete pro-
teoglycans that elute as two broad peaks; each of these peaks is
significantly increased following addition of TGF-131 (Fig. bA).
Following digestion with chondroitinase ABC, 60% of the
radioactivity was removed from the control conditioned me-
dium, whereas, 85% disappeared from the conditioned medium
from cells exposed to TGF-f3l (Fig. lOB). Nitrous acid specif-
ically digests heparan sulfate [251. When samples containing
these peaks remaining after chondroitinase ABC digestion were
treated with nitrous acid, the peaks disappeared and the radio-
activity was found in the void volume (data not shown). These
results were confirmed in three separate experiments and
indicate that the predominant effect of TGF-/31 on epithelial cell
proteoglycan production is on the synthesis of chondroitin/
dermatan sulfate proteoglycans, with little effect on the produc-
tion of heparan sulfate proteoglycans.
Effect of TGF-f3 on cell proliferation
An increase in extracellular matrix production by cultured
cell exposed to a growth factor, may be secondary to stimula-
tion of cell proliferation. Examination of 3H-thymidine incor-
poration as a measure of DNA synthesis and proliferation
showed that TGF-j3 added to subconfluent cultures of glomer-
ular epithelial cells reduced 3H-thymidine incorporation by an
average of 30% in three experiments (Fig. 11).
Discussion
The results of our study show that, among various growth
factors, TGF-131 alone increased extracellular matrix produc-
tion by cultured glomerular epithelial cells. Our results also
indicate a difference in the response to TGF-/3l between gb-
merular epithelial and mesangial cells. TGF-/31 strikingly in-
creased the production of fibronectin, type IV collagen and a
chondroitin/dermatan sulfate proteoglycan, biglycan, by epithe-
hal cells. In contrast, as demonstrated previously, the predom-
inant action of TGF-pI on mesangial cells was restricted to two
chondroitin/dermatan sulfate proteoglycans, biglycan and
decorin [15].
TGF-13l substantially increased the synthesis by glomerular
epithelial cells of both fibronectin, a glycoprotein found in
connective tissue matrices [261 and type IV collagen, a major
basement membrane protein [1, 7]. A lesser effect was seen on
another key basement membrane glycoprotein, laminin. In an
earlier study it was shown that TGF-J31 stimulated fibronectin
synthesis but did not affect the production of collagenase-
sensitive material by murine glomerular epithelial cells [27].
The fact that we found a clear increase in type IV collagen
synthesis may be due to the fact that we employed a different
species, and utilized immunoprecipitation to identify specific
collagen molecules.
TGF-/31, and probably TGF-32 and 3 are unique among
growth factors in the extent to which their multiple actions are
mediated through regulation of extracellular matrix synthesis
[11]. The glomerular epithelial cell can now be added to the list
of cell lines that have been shown to increase production of
matrix components following exposure to TGF-f31. The current
results also help illuminate our previous finding of increased
production of matrix components by cultured nephritic glomer-
uli [13]. We have shown that antibody induced injury to the
mesangial cell in vivo results in expression of TGF-/3l mRNA
and TGF-/31 protein in the nephritic glomeruli. Following
injury, cultured nephritic glomeruli were found to have in-
creased production of proteoglycans and fibronectin which
could be blocked by addition of anti-TGF-/31. Although the
experimental injury was confined to the mesangial cell, it is
likely that the newly released TGF-/3l induced matrix produc-
tion by both the mesangial cell and the glomerular epithelial
cell. Although both cell types could have contributed to the
increased proteoglycan production, the pattern of TGF-j31
stimulated matrix production revealed by the present study
suggests that the epithelial cells contribute to the increased
fibronectin, and other nonproteoglycan components, synthe-
sized by nephritic glomeruli and deposited into the expanded
mesangial matrix in experimental glomerulonephritis.
Nakamura et 0/: TGF-f31 regulates epithelial cell matrix production 1221
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